Penetration of teniposide (VM-26) into human intracerebral tumors.

Autor: Stewart, David, Richard, Michael, Hugenholtz, Herman, Dennery, Jean, Nundy, Dev, Prior, Judith, Montpetit, Vital, Hopkins, Harry
Zdroj: Journal of Neuro-Oncology; Dec1984, Vol. 2 Issue 4, p315-324, 10p
Abstrakt: Thirty-four consenting patients received VM-26 50-100 mg/m I.V. before surgical resection of intracerebral tumor, and drug was measured using a high pressure liquid chromatographic technique. Sufficient tumor for analysis was obtained from 29 patients. Brain metastases (13 patients) had higher concentrations of V M-26 than did gliomas (13 patients). Concentrations were comparable in brain metastases and meningiomas (3 patients). Prolonged (24 h) infusion of V M-26 did not appear to result in higher tumor drug concentrations in 5 patients than did rapid (1 h) infusion in 24 patients. Pretreatment with Amphotericin-B 10 mg/m 12 h and 1 h before VM-26 did not appear to have any effect on VM-26 uptake into 4 intracerebral tumors, although data were limited, and VM-26 concentrations were very high in 1 metastasis. Pretreatment with oral glycerol 500 mg/kg 18 h, 12 h, 6 h, and immediately before I.V. VM-26 may have resulted in increased penetration of VM-26 into 9 tumors, although confirmation is required. Amphotericin-B, glycerol, and operative conditions did not appear to alter VM-26 plasma pharmacokinetics. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index